Kazatomproms Q3 Production Surges 17 Signaling Strong Uranium Output Growth JDcom JD Gains Attention as a Potential Value Play Among NASDAQ Stocks Microns 2B Virginia Expansion Marks Milestone for Advanced DRAM Production in the US Trump Calls for Totally Independent Fed Chair Signaling Shift from Pressure Tactics CrowdStrike Regains Position on Elite Stock List SKIN Q1 2026 Earnings EPS Beats Estimates Despite Challenging Conditions EIG Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher CATO Q4 2025 Earnings Reported Loss of 055 Per Share Shares Decline 64 U Q1 2026 Earnings EPS Surprises to the Upside Stock Jumps 785 BAH Q1 2026 Earnings Strong EPS Beat Drives Share Gains Eve Holding Inc EVEX Edges Higher as Shares Test Key Resistance at 32 Healthcare Realty Trust HR Edges Lower Holds Above Key Support SiriusPoint SPNT Edges Lower as Stock Holds Above Key Support Zone Primo Brands Corporation PRMB Edges Up 143 Testing Resistance Near 2611 Origin Materials ORGN Holds Steady at 147 Key Levels in Focus Freight Technologies FRGT Slides 426 as Support Levels Come Into Focus Global Economic Turmoil Brews The Story Behind the 5 Coffee MDIA Q3 2023 Earnings Narrowed Loss Amidst Challenging Media Landscape Turkey Sees Strong Potential for Drone Development Partnership with Japan ADCT Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Surges FFIN Q1 2026 Earnings EPS Beat Surprise of 38 Drives Positive Stock Movement WTM Q2 2025 Earnings EPS Misses Estimates Amid Challenging Market Conditions LifeMD Q1 2026 Earnings EPS Beats Estimates by 1166 as Stock Rises 119 SKWD Q1 2026 Earnings EPS Surges Past Estimates Despite Limited Revenue Disclosure EXAS Q4 2025 Earnings Significant EPS Miss Amidst Challenging Quarter KNTK Q1 2026 Earnings Significant EPS Miss as Company Posts Surprise Loss FENG Q3 2024 Earnings Net Loss Deepens as Advertising Headwinds Persist Enveric Biosciences Inc ENVB Q4 2024 Earnings Massive EPS Miss Highlights Ongoing Cash Burn and No Revenue UK Childcare Costs Threaten Family Formation Government Reviews Hidden Charges AI Q1 2026 Earnings EPS Misses Estimates as Subscription Momentum Drives Stock Higher Akebia Therapeutics AKBA Edges Higher at 104 Key Levels in Focus